1 / 14

D isclosures

PTPN2 deficiency exacerbates epithelial barrier dysfunction in vivo and in vitro via redistribution of occludin and ZO-1. Ronald R. Marchelletta 1 , Lucas Bernts 1 , Stephan Myers 1 , Taylaur Smith 1 , Young Park 1 , Kim E Barrett 1 , Declan F McCole 2 1 University of California, San Diego

amos
Télécharger la présentation

D isclosures

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PTPN2 deficiency exacerbates epithelial barrier dysfunction in vivo and in vitro via redistribution of occludin and ZO-1 Ronald R. Marchelletta1, Lucas Bernts1, Stephan Myers1, Taylaur Smith1, Young Park1, Kim E Barrett1, Declan F McCole2 1University of California, San Diego 2University of California, Riverside

  2. Disclosures • Nothing to disclose

  3. Gastrointestinal Barrier • Aids in the absorption of nutrients while excluding harmful molecules and bacteria. • Defective epithelial barrier is a hallmark of UC and CD. • Barrier dysfunction is in part driven by IFNgsignaling. • Genome-Wide Association Studies show that SNP in Protein Tyrosine Phosphatase N2 is Associated with increase incidence of CD and UC. Abreu, Reviews Immunology 10, 131-144 (February 2010)

  4. PTPN2 Restricts IFNg-Mediated Barrier Dysfunction • PTPN2 is a negative regular of IFNgsignaling. • PTPN2 protects epithelial barrier function. • Loss of PTPN2 causes: • Increased epithelial permeability • Decreased epithelial resistance Scharl, M et al., Gastroenerology, 2009 McCole, DF, NY Academy of Science, 2012

  5. Tight-Junction Turner JR. Nat Rev Immunol 2009;9:799-809. Ivanov AI. Am J Pathol. 2010 Aug;177(2):512-24

  6. PTPN2 KO Mice Show Increased Permeability in Proximal Colon • Mount tissue in Ussing Chamber • Applied FD4 to the mucosal side • Sampled at the serosal side (2 hours). humanbiology.wzw.tum.de

  7. Mislocalization of Occludin & ZO-1 from tight junctions in PTPN2 KO mouse colon Arrows indicate location of tight junctions. Knock-out exhibits internalization and mislocalization of occludin.

  8. C216S Mutant Cell line • HCA7 intestinal epithelial cell line • 216 Cysteine to Serine (C216S) • Lentiviral Vector • Doxycycline activation

  9. Detection of HA Tag in C216S-Transduced Cells • HA-TC45 expression confirmed in DOX induced condition • Nearly 3-fold increase in PTPN2 with increased transactivator protein

  10. C216S expressing cells show increased phospho-STAT1

  11. ZO-1 and Occludin are reduced in C216S mutant cell line

  12. PTPN2 mutant cells show reduced occludin/ZO-1 co-localization *

  13. Conclusion • PTPN2 KO mice show increased colonic FITC-dextran permeability. • Occludin appears mislocalized from the tight junctions in PTPN2 KO. • C216S mutant cells have altered tight junction composition. • Therefore, loss of PTPN2 expression or activity in vivo and in vitro compromises barrier function possibly through occludin mislocalization.

  14. Acknowledgements • Michel Tremblay – McGill University • Tony Tiganis – Monash University

More Related